Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Monjori, Mitra"'
Autor:
Krishna Kumari P, Siddharth Reddy Chiteti, Vinay K. Aileni, Sudhir Babji, William C. Blackwelder, Ashok Kumar, Jayant Vagha, Uma Nayak, Monjori Mitra, Narayanaappa D, Sonali Kar, Sangeeta Yadav, Swamy Naidu, Niranjan Mahantshetti, Vasant Khalatkar, Satyajit Mohapatra, P. K. Purthi, Pawan Sharma, A. Kannan, Ramchandra Keshav Dhongade, Sai D. Prasad, Raches Ella, Krishna Mohan Vadrevu
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 3 (2023)
ABSTRACTThe WHO pre-qualified rotavirus vaccine, ROTAVAC®, is derived naturally from the neonatal 116E rotavirus strain, and stored at −20°C. As refrigerator storage is preferable, immunogenicity and safety of liquid formulations kept at 2–8°C
Externí odkaz:
https://doaj.org/article/55f5afb8006c4ff9987084f822460370
Autor:
Arun Wadhwa, Dhanasekhar Kesavelu, Kishore Kumar, Pallab Chatterjee, Pramod Jog, Sarath Gopalan, Rudra Paul, Krishna Chaitanya Veligandla, Suyog Mehta, Amey Mane, Sucheta Pandit, Rahul Rathod, Sushma Jayan, Monjori Mitra
Publikováno v:
Clinics and Practice, Vol 12, Iss 1, Pp 37-45 (2022)
Background: Infantile colic is characterized by prolonged periods of inconsolable, incessant crying and persistent fussing in an otherwise healthy infant. It is a self-limiting condition, but causes significant stress to mothers. AIM: To observe the
Externí odkaz:
https://doaj.org/article/abbdfe73f84a458bacd1d538f13e3285
Autor:
Krishna Mohan Vadrevu, Raju Dugyala, Niranjana Shamulinga Mahantashetti, Vasant Khalatkar, Krishna Murthy, Sandeep Mogre, Monjori Mitra
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 7 (2022)
We evaluated safety, reactogenicity, and immunogenicity when the WHO-prequalified single-dose Typhoid Vi-polysaccharide conjugate vaccine, Typbar-TCV®, was administered concomitantly with measles (MV) or measles-mumps-rubella (MMR) vaccines in 8- or
Externí odkaz:
https://doaj.org/article/0db655c876454a29bedd80b05a81ca7a
Autor:
Catherine Cohet, Brigitte Cheuvart, Leentje Moerman, Dan Bi, Adrian Caplanusi, Mallesh Kariyappa, Sanjay Lalwani, Monjori Mitra, Amita Sapru, Shruti Saha, P.V. Varughese, Rajeev Zachariah Kompithra, Sanjay Gandhi
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4646-4653 (2021)
The human rotavirus vaccine (HRV; Rotarix, GSK) is available as liquid (Liq) and lyophilized (Lyo) formulations, but only Lyo HRV is licensed in India. In this phase III, randomized, open-label trial (NCT02141204), healthy Indian infants aged 6–10
Externí odkaz:
https://doaj.org/article/5d35f76d2617450b9901c97811e1abfb
Autor:
Nitin Shah, MMA Faridi, Monjori Mitra, Ashish Bavdekar, Archana Karadkhele, Gaurav Puppalwar, Rishi Jain
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 11, Pp 2816-2821 (2020)
Hepatitis A represents one of the major public health problems worldwide including India. Vaccination is the most effective way to prevent hepatitis A infection. Two types of hepatitis A vaccines-live attenuated (H2 strain) and inactivated (killed) a
Externí odkaz:
https://doaj.org/article/0dbe5bfb29d541c28ac29ea5842e1758
Autor:
Ashish Agrawal, Shafi Kolhapure, Anar Andani, Martin O. C. Ota, Selim Badur, Naveen Karkada, Monjori Mitra
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 785-796 (2020)
Abstract Introduction Hepatitis A virus infection is more severe in adults than children. Although vaccination can protect adults, current childhood programs cover a large population more successfully. Childhood vaccination is, therefore, a solution
Externí odkaz:
https://doaj.org/article/b4111448187241bdb9099bd61a6e323e
Publikováno v:
Infectious Diseases and Therapy, Vol 8, Iss 4, Pp 483-497 (2019)
Abstract Hepatitis A, an acute inflammatory liver disease caused by hepatitis A virus (HAV) infection from close contact with infected people, is highly endemic in the Indian subcontinent. Due to poor sanitary conditions, most of the population is ex
Externí odkaz:
https://doaj.org/article/555716b0cced4df1825b30066ed1a9bc
Autor:
Michael A. Portman, Jeffrey P. Jacobs, Jane W. Newburger, Felix Berger, Michael A. Grosso, Anil Duggal, Ben Tao, Neil A. Goldenberg, Matthew Brothers, Bradley Marino, Charles Canter, Mark Law, Nguyenvu Nguyen, Charlie Sang, Kristin Shimano, Dipankar Gupta, Michael Portman, Derek Williams, Lauren Glass, Charles Sperrazza, Steven Herold, Ruchira Garg, Mark Vranicar, Sawsan Awad, Alfred Asante-Korang, Colleen Druzgal, Caroline Ozment, Kamill Del Toro, Ferran Roses, Christian Jux, Verena Gravenhorst, Ulrich Schweigmann, Mihir Bhatt, Christine Sabapathy, Nagib Dahdah, Dototea Bartonicek, Gerald Tulzer, Elena Basargina, Tatiana Zvereva, Tatiana Pertels, Irina Plotnikova, S.E.G.U.E.L.A. Pierre-Emmanuel, Pascal Amedro, Dulac Yves, Damien BONNET, Paola Saraco, Alessandro Rimini, Valerii Digtiar, Margaryta Gonchar, Tetyana Kryuchko, Olga Yablon, Varinder Singh Bedi, Jashvant Patel, Monjori Mitra, Jacek Kusa, Kowalczyk Domagala, László KÖRNYEI, Csaba BERECZKI, László ABLONCZY, Vivianne Aviva Levitas, David Mishali, Shoshana Revel-Vilk, Dan Harlev, Hatice Ilgen Sasmaz, Namik Yasar Ozbek, Sule Unal, Türkan Patıroglu, Baris Malbora, Hasan Agin, Zeynep Karakas, Ramazan Kaan Kavakli, Elizabeth Chalmers, Frances Bu'Lock, Piers Daubeney, Hala Hamza, Mohamed Badr, Mohsen Elalfy, Ahmed Mansour, Hoda Hassab, Ayman Sabry, Linda Daou, Fadi Bitar
Publikováno v:
Journal of the American College of Cardiology. 80:2301-2310
Standard of care (SOC) anticoagulation for thromboembolism (TE) prevention in children with cardiac disease includes low molecular weight heparins or vitamin K antagonists. Limited data exists for alternate use of direct oral anticoagulants in childr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bc9820f0798cc8f0ac3ae00a75a96f1
https://doi.org/10.1016/j.jacc.2022.09.031
https://doi.org/10.1016/j.jacc.2022.09.031
Autor:
Monjori Mitra, Jaydeep Chowdhury, Surupa Basu, Partha Pratim Halder, Mallar Mukherjee, Archana Karadkhele, Gaurav Puppalwar, Rishi Jain
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 8 (2020)
Background: In India, where varicella outbreaks are reported at a younger age, a two-dose vaccine schedule administered at an early age could be highly efficacious in preventing varicella infection. The aim of this study was to evaluate the immunogen
Externí odkaz:
https://doaj.org/article/d80486d3f72247c4a9c5d9f65f8c01a5
Publikováno v:
BLDE University Journal of Health Sciences, Vol 3, Iss 1, Pp 36-42 (2018)
AIMS: To determine the efficacy of measuring the transcutaneous bilirubin as a screening tool for clinically significant hyperbilirubinaemia in Indian infants. MATERIALS AND METHODS: A cohort of 100 neonates who have clinical jaundice, admitted in NI
Externí odkaz:
https://doaj.org/article/625be261acc64aa294e1848f3854ab6e